title: Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.
abstract: With the eruption of the obesity pandemic over the past few decades, much research has been devoted to understanding the molecular mechanisms by which the human body regulates energy balance. These studies have revealed several mediators, including gut/pancreatic/adipose hormones and neuropeptides that control both short- and long-term energy balance by regulating appetite and/or metabolism. These endogenous mediators of energy balance have been the focus of many anti-obesity drug-development programs aimed at either amplifying endogenous anorexigenic/lipolytic signaling or blocking endogenous orexigenic/lipogenic signaling. Here, we discuss the efficacy and safety of targeting these pathways for the pharmacologic treatment of obesity.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 132 South 10th Street, 1170 Main, Philadelphia, PA 19107, USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Valentino
authors.forename: Francheska
authors.initials: F
authors.lastname: Colon-Gonzalez
authors.forename: Jieru E
authors.initials: JE
authors.lastname: Lin
authors.forename: Scott A
authors.initials: SA
authors.lastname: Waldman